BRIEF-Corcept Therapeutics reports Q4 preliminary GAAP earnings per share $0.04
* Corcept Therapeutics announces preliminary fourth quarter and full-year 2016 financial results and corporate update; provides 2017 revenue guidance [Source]
Publication Date:Origin: reuters.com
Category: rbssHealthcareNews
Topics: preliminary, Therapeutics, guidance, revenue, update; provides, corporate, results, financial, full-year, quarter and, fourth, announces, Corcept, share, earnings, reports, BRIEF-Corcept
Source: http://feeds.reuters.com/~r/reuters/UShealthcareNews/~3/VdUSOFD6ep8/idUSASB0AXG3